Werbung ausblenden

News zu TRANSGENE

Transgene: Balance Sheet of the Liquidity Contract With Natixis Oddo BHF SCA as of December 31, 2022 · Uhr · Business Wire
Transgene Appoints Steven Bloom as Chief Business Officer · Uhr · Business Wire
Transgene and BioInvent Joint JITC Publication Demonstrates the Potential of BT-001 Oncolytic Virus to Provide Therapeutic Benefit Beyond Current Anti-PD1/ Anti-CTLA-4 Immune Checkpoint Blockade · Uhr · Business Wire
Transgene Announces Financial Calendar for 2022 · Uhr · Business Wire
Transgene: Balance Sheet of the Liquidity Contract with Natixis Oddo BHF SCA as of December 31, 2021 · Uhr · Business Wire
Transgene Announces Investor Meetings for January 2022 · Uhr · Business Wire
Transgene announces License Option Exercise by AstraZeneca for an Oncolytic Virus Generated by Transgene’s Invir.IO™ Platform · Uhr · Business Wire
Transgene and NEC Announce Positive Preliminary Data From Phase I Studies of TG4050, a Novel Individualized Neoantigen Cancer Vaccine · Uhr · Business Wire
Transgene and BioInvent Present Preclinical Data Highlighting the Robust Anti-Tumoral Activity of BT-001 Oncolytic Virus at SITC 2021 · Uhr · Business Wire
Transgene Reports Business Update and Q3 2021 Financial Position · Uhr · Business Wire